Skip to content
Delayed ~15 min

AURA AURA BIOSCIENCES

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Thu 12 Nov 2026 · estimated

What 8 analyst firms say about AURA BIOSCIENCES: their latest ratings, price targets and how far the stock is from them. How it works

6.56 USD+0.22 (+3.47%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+156.1%to the avg target 16.80 USD+10.24 USD
Buy 6 · Hold 1 · Sell 0

7 rated views · 8 analyst/firm records · 8 firms

Latest report11 Aug 2026avg report date 25 May
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (2)
  • Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (2)

Recent analyst activity · last 90 days

Our tracked history has 3 reports on AURA from 3 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 2 lowered it.

No firm's latest available rating differs from its previous one.

Latest observed target change: H.C. Wainwright lowered its target from $24.00 (set 29 Apr 2026) to $18.00 on 11 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Citizens JMPJonathan WollebenBuy30 Mar 202616.00 USD
Evercore ISIJonathan MillerBuy10 Apr 202615.00 USD
H.C. WainwrightAndres Y. MaldonadoBuy11 Aug 202618.00 USD
Leerink PartnersAndrew BerensBuy11 Aug 202612.00 USD
Lifesci CapitalOliver MccammonBuy31 Mar 202623.00 USD
TD CowenPhilip M NadeauBuy15 Jun 2026—
Weiss RatingsUnnamed analyst—12 Oct 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:59 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.